Dr. Elmar Burchardt is a seasoned professional with a diverse background in healthcare, pharmaceuticals, and research. As the Managing Director and CEO of Boston Healthcare Technologies Consultants L.L.C., he brings a wealth of experience from his previous roles, including President and CEO of Hemostemix Inc. and Vice President at Pfizer Inc.
Dr. Burchardt’s expertise extends beyond the boardroom; he maintains an active presence in academia as an Adjunct Professor of Clinical Pharmacology at the University of Witten-Herdecke, Germany. His career is further distinguished by his extensive research background, with notable contributions at Bayer AG and numerous publications in scientific journals. He holds multiple degrees, including a D.Sc. and two Ph.D.s, underscoring his commitment to scientific inquiry and advanced studies.